KAITLYN STURMER: Open Payments
NPI 1003445404 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$670 in 33 payments from 14 companies in 2025. Trend: 2023 $300 · 2024 $793 · 2025 $670
Food & beverage: $670
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 14 | $301 |
| Novo Nordisk Inc | 5 | $101 |
| Exact Sciences Corporation | 2 | $41 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $30 |
| AstraZeneca Pharmaceuticals LP | 2 | $29 |
| Xeris Pharmaceuticals, Inc. | 1 | $25 |
| ABBVIE INC. | 1 | $23 |
| Sumitomo Pharma America, Inc. | 1 | $20 |
| Amgen Inc. | 1 | $19 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19 |
Products named: MOUNJARO, Cologuard Collection Kit, Ozempic, JARDIANCE, TRINTELLIX, GVOKE HYPOPEN, VRAYLAR, GEMTESA.
Industry payments across MO — which companies pay providers there.
